| Results of a strategy integrating transfemoral and transapical aortic valve implantation in high-risk patients with aortic stenosis. | D Himbert (Paris, FR) | Valvular disease | 02 Sep 2009 |
| Transcatheter aortic valve implantation in patients with low Euroscore but presenting with anatomical or technical contraindications to conventional surgery. | M Taramasso (Milan, IT) | Valvular disease | 02 Sep 2009 |
| Initial experiences with a non-stented coronary sinus device for the treatment of functional mitral regurgitation: results of the PTOLEMY I feasibility trial. | S Sack (Munich, DE) | Valvular disease | 02 Sep 2009 |
| Percutaneous treatment of the mitral regurgitation with the MitraClip System in patients with severely reduced left ventricular function - first european experience. | O W Franzen (Hamburg, DE) | Valvular disease | 02 Sep 2009 |
| State of the Art - Percutaneous valve intervention. Where is it going? | B Iung (Paris Cedex 18, FR) | Valvular disease | 02 Sep 2009 |
| Impact of bleeding types on mortality after PCI: Results from a patient-level pooled analysis of the REPLACE-2, ACUITY and HORIZONS trials. | R Mehran (New York, US) | Interventional cardiology | 02 Sep 2009 |
| REPLACE-2, ACUITY, HORIZONS: Discussant. | W Wijns (Aalst, BE) | Interventional cardiology | 02 Sep 2009 |
| Survival in patients with heart failure and preserved versus impaired left ventricular ejection fraction: an individual patient data meta-analysis: MAGGIC. | R Doughty (Auckland, NZ) | Heart failure / LV dysfunction | 02 Sep 2009 |
| RE-LY: Discussant. | J-P Collet (Paris, FR) | Arrhythmias / Pacing / Resynchronisation | 02 Sep 2009 |
| Clinical outcome after thrombectomy or standard angioplasty in patients with ST elevation myocardial infarction: individual patient-data pooled analysis of 11 randomized trials. ATTEMPT. | F Burzotta (Roma, IT) | Ischaemia / ACS / infarction | 02 Sep 2009 |
| ATTEMPT: Discussant. | E Eeckhout (Lausanne, CH) | Ischaemia / ACS / infarction | 02 Sep 2009 |
| Optimal revascularization strategy in patients with three-vessel disease and/or left main disease: The 2 year outcomes of the SYNTAX Trial. | AP Kappetein (Rotterdam, NL) | Ischaemia / ACS / infarction | 02 Sep 2009 |
| SYNTAX: Discussant. | M J Antunes (Coimbra, PT) | Ischaemia / ACS / infarction | 02 Sep 2009 |
| Fractional Flow Reserve versus Angiography for Guiding PCI - 2 year outcome. | N H J Pijls (Eindhoven, NL) | Interventional cardiology | 02 Sep 2009 |
| FFR vs Angriography for Guiding PCI: Discussant. | T F Luescher (Zurich, CH) | Interventional cardiology | 02 Sep 2009 |
| Basic science: Highlight Session | B Casadei (Oxford, GB) | Cardiovascular system (patho)physiology | 02 Sep 2009 |
| Hypertension and risk factors: Highlight Session | R Fagard (Leuven, BE) | Hypertension | 02 Sep 2009 |
| Imaging: Highlight Session | F E Rademakers (Leuven, BE) | Myocardial-Pericardial disease | 02 Sep 2009 |
| Arrhythmias: Highlight Session | P E Vardas (Heraklion, GR) | Arrhythmias / Pacing / Resynchronisation | 02 Sep 2009 |
| Acute coronary syndromes: Highlight Session | K A A Fox (Edinburgh, GB) | Ischaemia / ACS / infarction | 02 Sep 2009 |
| Interventional cardiology: Highlight Session | C Di Mario (London, GB) | Interventional cardiology | 02 Sep 2009 |
| Valvular heart disease: Highlight Session | R Rosenhek (Wien, AT) | Valvular disease | 02 Sep 2009 |
| Heart failure and cardiomyopathies: Highlight Session | M Metra (Brescia, IT) | Heart failure / LV dysfunction | 02 Sep 2009 |
| Prevention: Highlight Session | J Perk (Oskarshamn, SE) | Epidemiology & prevention | 02 Sep 2009 |
| MAGGIC: Discussant. | DM Kaye (Melbourne, AU) | Heart failure / LV dysfunction | 02 Sep 2009 |